Bal Pharma Limited has informed the Exchange regarding Change in Director(s) of the company.
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bal Pharma Limited has appointed Mr. Ravindra Kumar Kothari as an Additional Director (non-executive and non-independent) on the Board, effective May 5, 2025, via a circular resolution. He will hold office until the conclusion of the next Annual General Meeting or three months from appointment, whichever is earlier. Mr. Kothari, born in 1955, is a Commerce graduate with about 45 years of experience in administration, legal, and statutory functions. He holds 2,437 shares in the company and also serves on the boards of Lifezen Healthcare Private Ltd, Bal Research Foundation, and Balance Clinics LLP. He has not been debarred from holding directorship by any authority.
This is a routine Board-level addition with no immediate material impact on shareholders. The non-independent nature of the appointment and his directorship in 'Bal Research Foundation' suggest a likely promoter-group or insider connection, which shareholders may note for governance reasons.